MENU
+Compare
RDY
Stock ticker: NYSE
AS OF
Oct 21, 02:16 PM (EDT)
Price
$14.74
Change
-$0.01 (-0.07%)
Capitalization
12.13B

RDY Dr. Reddy's Laboratories Ltd Forecast, Technical & Fundamental Analysis

RDY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for RDY with price predictions
Oct 20, 2025

Momentum Indicator for RDY turns positive, indicating new upward trend

RDY saw its Momentum Indicator move above the 0 level on October 16, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 84 similar instances where the indicator turned positive. In of the 84 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for RDY just turned positive on October 16, 2025. Looking at past instances where RDY's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

RDY moved above its 50-day moving average on October 17, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RDY advanced for three days, in of 332 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 265 cases where RDY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for RDY moved out of overbought territory on September 18, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The 10-day moving average for RDY crossed bearishly below the 50-day moving average on October 03, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RDY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

RDY broke above its upper Bollinger Band on October 17, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. RDY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.087) is normal, around the industry mean (17.836). P/E Ratio (19.060) is within average values for comparable stocks, (73.337). Projected Growth (PEG Ratio) (3.271) is also within normal values, averaging (2.094). RDY has a moderately low Dividend Yield (0.006) as compared to the industry average of (0.031). P/S Ratio (3.238) is also within normal values, averaging (47.402).

View a ticker or compare two or three
RDY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

RDY is expected to report earnings to fall 2.35% to 19 cents per share on October 24

Dr. Reddy's Laboratories Ltd RDY Stock Earnings Reports
Q3'25
Est.
$0.20
Q2'25
Missed
by $0.01
Q1'25
Beat
by $0.01
Q4'24
Missed
by $0.01
Q3'24
Missed
by $0.03
The last earnings report on July 23 showed earnings per share of 20 cents, missing the estimate of 20 cents. With 43.77K shares outstanding, the current market capitalization sits at 12.13B.
A.I.Advisor
published Dividends

RDY paid dividends on August 06, 2025

Dr. Reddy's Laboratories Ltd RDY Stock Dividends
А dividend of $0.09 per share was paid with a record date of August 06, 2025, and an ex-dividend date of July 25, 2025. Read more...
A.I. Advisor
published General Information

General Information

a developer of pharmaceuticals

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Generic
Address
8-2-337, Road No. 3
Phone
+91 4049002900
Employees
25863
Web
https://www.drreddys.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
AFSC30.310.50
+1.69%
abrdn Focused U.S. Small Cap Active ETF
USSE33.290.39
+1.18%
Segall Bryant & Hamill Select Equity ETF
ITDC34.350.26
+0.75%
iShares LifePath Target Date 2035 ETF
HYGV40.980.12
+0.31%
FlexShares HY Val-Scrd Bd
FINE22.00N/A
N/A
Themes ETF Trust Themes European Luxury ETF

RDY and Stocks

Correlation & Price change

A.I.dvisor tells us that RDY and COLL have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RDY and COLL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDY
1D Price
Change %
RDY100%
+2.08%
COLL - RDY
30%
Poorly correlated
+2.68%
AVDL - RDY
28%
Poorly correlated
+3.81%
HROW - RDY
27%
Poorly correlated
+5.30%
VTRS - RDY
27%
Poorly correlated
+1.38%
TAK - RDY
25%
Poorly correlated
+0.28%
More

Groups containing RDY

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDY
1D Price
Change %
RDY100%
+2.08%
Pharmaceuticals: Generic
industry (217 stocks)
30%
Poorly correlated
-0.01%